Natixis Investment Managers International’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Natixis Investment Managers International's ABBV Position: Q3 2022 in Review
Natixis Investment Managers International sold out of AbbVie (ABBV) in Q3 2022, closing a stake of 14,935 shares — an estimated $2.29M sold.
Natixis Investment Managers International first reported a position in ABBV in Q4 2014 and held it in 17 quarters. The position peaked at $2.4M in Q1 2022. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.
- Natixis Investment Managers International reported no remaining AbbVie position as of Q3 2022 after selling out during the quarter.
- Natixis Investment Managers International sold 14,935 AbbVie shares in Q3 2022, an estimated $2.29M.
- Natixis Investment Managers International first reported a position in AbbVie in Q4 2014 and held it in 17 quarters.
- Natixis Investment Managers International's AbbVie position peaked at $2.4M in Q1 2022.
- 2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.
Based on Natixis Investment Managers International's 13F filing for Q3 2022, filed 14 Nov 2022.